Schedule 13D ownership disclosure

IGC PHARMA INC

Security class unavailable · CUSIP: 45408X308

Event date: 2024-03-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,823,529
Percent of class
18.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001185185-24-000580
Form type
SC 13D
Filer
Bradbury Strategic Investment Fund A (Cayman Islands Registr
CIK
CIK 2022777
Filed
May 21, 2024
Reporting period
Mar 22, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub